Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon.

Petrikovics I, Papahadjopoulos D, Hong K, Cheng TC, Baskin SI, Jiang J, Jaszberenyi JC, Logue BA, Szilasi M, McGuinn WD, Way JL.

Toxicol Sci. 2004 Feb;77(2):258-62. Epub 2003 Jul 11.

PMID:
12857941
2.

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC.

Clin Cancer Res. 2002 Apr;8(4):1172-81.

3.

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID:
11489487
4.

Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR.

Goncz KK, Colosimo A, Dallapiccola B, Gagné L, Hong K, Novelli G, Papahadjopoulos D, Sawa T, Schreier H, Wiener-Kronish J, Xu Z, Gruenert DC.

Gene Ther. 2001 Jun;8(12):961-5.

5.

Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism.

Petrikovics I, Cheng TC, Papahadjopoulos D, Hong K, Yin R, DeFrank JJ, Jaing J, Song ZH, McGuinn WD, Sylvester D, Pei L, Madec J, Tamulinas C, Jaszberenyi JC, Barcza T, Way JL.

Toxicol Sci. 2000 Sep;57(1):16-21.

PMID:
10966507
6.

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism.

Petrikovics I, McGuinn WD, Sylvester D, Yuzapavik P, Jiang J, Way JL, Papahadjopoulos D, Hong K, Yin R, Cheng TC, DeFrank JJ.

Drug Deliv. 2000 Apr-Jun;7(2):83-9.

PMID:
10892408
7.

Anti-HER2 immunoliposomes for targeted drug delivery.

Hong K, Kirpotin DB, Park JW, Shao Y, Shalaby R, Colbern G, Benz CC, Papahadjopoulos D.

Ann N Y Acad Sci. 1999;886:293-6. Review. No abstract available.

PMID:
10667243
8.

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D.

Pharmacol Rev. 1999 Dec;51(4):691-743. Review. No abstract available.

PMID:
10581328
9.

Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.

Petrikovics I, Hong K, Omburo G, Hu QZ, Pei L, McGuinn WD, Sylvester D, Tamulinas C, Papahadjopoulos D, Jaszberenyi JC, Way JL.

Toxicol Appl Pharmacol. 1999 Apr 1;156(1):56-63.

PMID:
10101099
10.
11.

Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.

Meyer O, Kirpotin D, Hong K, Sternberg B, Park JW, Woodle MC, Papahadjopoulos D.

J Biol Chem. 1998 Jun 19;273(25):15621-7.

12.

Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats.

Zhang W, Guo L, Nadel JA, Papahadjopoulos D.

Pharm Res. 1998 Mar;15(3):455-60.

PMID:
9563077
13.

Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes.

Meyer O, Papahadjopoulos D, Leroux JC.

FEBS Lett. 1998 Jan 2;421(1):61-4.

14.

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

Park JW, Hong K, Kirpotin DB, Meyer O, Papahadjopoulos D, Benz CC.

Cancer Lett. 1997 Oct 14;118(2):153-60.

PMID:
9459205
15.

Simultaneous measurement of liposome extravasation and content release in tumors.

Wu NZ, Braun RD, Gaber MH, Lin GM, Ong ET, Shan S, Papahadjopoulos D, Dewhirst MW.

Microcirculation. 1997 Mar;4(1):83-101.

PMID:
9110286
16.

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D.

Biochemistry. 1997 Jan 7;36(1):66-75.

PMID:
8993319
18.

Immunoliposomes for cancer treatment.

Park JW, Hong K, Kirpotin DB, Papahadjopoulos D, Benz CC.

Adv Pharmacol. 1997;40:399-435. Review. No abstract available.

PMID:
9217932
19.

Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks.

Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1177-87.

PMID:
8985041
20.

Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma.

Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K, Dewhirst MW.

Cancer Res. 1996 Dec 1;56(23):5522-8.

21.

Increased liposome extravasation in selected tissues: effect of substance P.

Rosenecker J, Zhang W, Hong K, Lausier J, Geppetti P, Yoshihara S, Papahadjopoulos D, Nadel JA.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7236-41.

22.

Microvascular studies on the origins of perfusion-limited hypoxia.

Dewhirst MW, Kimura H, Rehmus SW, Braun RD, Papahadjopoulos D, Hong K, Secomb TW.

Br J Cancer Suppl. 1996 Jul;27:S247-51.

24.

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes.

Friend DS, Papahadjopoulos D, Debs RJ.

Biochim Biophys Acta. 1996 Jan 12;1278(1):41-50.

25.
26.

Liposomes revisited.

Lasic DD, Papahadjopoulos D.

Science. 1995 Mar 3;267(5202):1275-6. Review. No abstract available.

PMID:
7871422
27.

Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK.

Cancer Res. 1994 Jul 1;54(13):3352-6.

28.

Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.

Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D.

Cancer Res. 1994 Apr 15;54(8):2186-91.

29.

The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome.

Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP.

Transplantation. 1994 Mar 27;57(6):928-32.

PMID:
8154042
30.

Conjugation of apolipoprotein B with liposomes and targeting to cells in culture.

Lundberg B, Hong K, Papahadjopoulos D.

Biochim Biophys Acta. 1993 Jul 4;1149(2):305-12.

PMID:
8391843
31.

Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene.

Huang SK, Martin FJ, Jay G, Vogel J, Papahadjopoulos D, Friend DS.

Am J Pathol. 1993 Jul;143(1):10-4.

33.

Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.

Huang SK, Mayhew E, Gilani S, Lasic DD, Martin FJ, Papahadjopoulos D.

Cancer Res. 1992 Dec 15;52(24):6774-81.

34.

Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells.

Lee KD, Pitas RE, Papahadjopoulos D.

Biochim Biophys Acta. 1992 Oct 19;1111(1):1-6.

PMID:
1390854
35.

Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.

Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D.

Cancer Res. 1992 Oct 1;52(19):5135-43.

36.

Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.

Woodle MC, Matthay KK, Newman MS, Hidayat JE, Collins LR, Redemann C, Martin FJ, Papahadjopoulos D.

Biochim Biophys Acta. 1992 Apr 13;1105(2):193-200.

PMID:
1586658
37.

Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential.

Woodle MC, Collins LR, Sponsler E, Kossovsky N, Papahadjopoulos D, Martin FJ.

Biophys J. 1992 Apr;61(4):902-10.

38.
39.

The role of surface charge and hydrophilic groups on liposome clearance in vivo.

Gabizon A, Papahadjopoulos D.

Biochim Biophys Acta. 1992 Jan 10;1103(1):94-100.

PMID:
1309663
40.

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C, et al.

Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11460-4.

41.

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times.

Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D.

Biochim Biophys Acta. 1991 Nov 18;1070(1):187-92.

PMID:
1751525
42.

Increased binding of liposomes to cells by electric treatment.

Chernomordik LV, Papahadjopoulos D, Tsong TY.

Biochim Biophys Acta. 1991 Nov 18;1070(1):193-7.

PMID:
1661151
43.

Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues.

Huang SK, Hong K, Lee KD, Papahadjopoulos D, Friend DS.

Biochim Biophys Acta. 1991 Oct 14;1069(1):117-21.

PMID:
1932044
44.

Interactions of annexins with membrane phospholipids.

Meers P, Daleke D, Hong K, Papahadjopoulos D.

Biochemistry. 1991 Mar 19;30(11):2903-8.

PMID:
1826088
45.

Characterization of a cyclosporine-containing liposome.

Freise CE, Hong K, Clemens LE, Papahadjopoulos D, Burke E, Martinez O, Lake J, Ascher NL, Roberts JP.

Transplant Proc. 1991 Feb;23(1 Pt 1):473-4. No abstract available.

PMID:
1824989
46.

Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.

Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D.

Cancer Res. 1990 Oct 1;50(19):6371-8.

47.

Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay.

Daleke DL, Hong K, Papahadjopoulos D.

Biochim Biophys Acta. 1990 May 24;1024(2):352-66.

PMID:
2162207
48.

Endocytosis and intracellular fate of liposomes using pyranine as a probe.

Straubinger RM, Papahadjopoulos D, Hong KL.

Biochemistry. 1990 May 22;29(20):4929-39.

PMID:
2163672
49.

Molecular mechanisms of calcium-induced membrane fusion.

Papahadjopoulos D, Nir S, Düzgünes N.

J Bioenerg Biomembr. 1990 Apr;22(2):157-79. Review.

PMID:
2139437
50.

Membrane contact, fusion, and hexagonal (HII) transitions in phosphatidylethanolamine liposomes.

Allen TM, Hong K, Papahadjopoulos D.

Biochemistry. 1990 Mar 27;29(12):2976-85.

PMID:
2337577

Supplemental Content

Loading ...
Support Center